Daniel Ramirez built his career across industrial engineering, McKinsey, Coca-Cola innovation, and pharma venture building at LEO Pharma before moving into early-stage investing at 10VC, and he treats a deal as only half finished once it's signed, staying closely involved—often checking in with founders every other week—to help the decision turn out right, especially when backing platform technologies or scientist-led biotech teams that have already shown real progress. His time in corporate venture at LEO Pharma shaped his belief that the best startup-corporate partnerships should cost the company little while bringing the startup a lot of value, and he sees today's platforms as likely to become tomorrow's features within a bigger platform.